Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

22. August 2025 19:39 ET | Quelle: Robbins LLP

PUBM Stockholder Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against PubMatic, Inc.

Robbins LLP is Investigating Allegations that PubMatic, Inc. (PUBM) Misled Investors Regarding its Business Prospects
22. August 2025 19:38 ET | Quelle: Robbins LLP

SNAP Stockholder Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against Snap Inc.

Robbins LLP is Investigating Allegations that Snap Inc. (SNAP) Misled Investors Regarding its Business Prospects
22. August 2025 19:14 ET | Quelle: Robbins LLP

SLQT Stockholders with Large Losses Should Contact Shareholder Rights Law Firm Robbins LLP for Information About the SelectQuote, Inc. Class Action

Robbins LLP is Investigating Allegations that SelectQuote, Inc. (SLQT) Violated the False Claims Act
18. August 2025 17:56 ET | Quelle: Robbins LLP

Robbins LLP Reminds Sarepta Therapeutics, Inc. Stockholders of the Pending Lead Plaintiff Deadline in the Securities Class Action Against SRPT

Robbins LLP is Investigating Allegations that Sarepta Therapeutics, Inc. (SRPT) Mislead Investors Regarding the Safety its ELEVIDYS Drug
14. August 2025 19:28 ET | Quelle: Robbins LLP

Robbins LLP Urges LINE Investors with Large Losses to Contact the Firm for Information About Leading the LINE Securities Fraud Class Action

Robbins LLP is Investigating Allegations that Lineage, Inc. (LINE) Misled Investors in Connection with its IPO
14. August 2025 19:25 ET | Quelle: Robbins LLP

Robbins LLP Urges NVO Stockholders with Large Losses to Contact the Firm for Information about Leading the Class Action Against Novo Nordisk A/S

Robbins LLP is Investigating Allegations that Novo Nordisk A/S (NVO) Misled the Market About its 2025 Revenue and Profit Growth Potential
14. August 2025 19:22 ET | Quelle: Robbins LLP

ANRO Investors: If You Have Suffered Large Losses Contact Robbins LLP for Information About Leading the Alto Neuroscience, Inc. Class Action Lawsuit

Robbins LLP is Investigating Allegations that Alto Neuroscience, Inc. (ANRO) Misled Investors Regarding the Viability of its Drug Candidate
12. August 2025 17:19 ET | Quelle: Robbins LLP

CTO Shareholder Notice: Robbins LLP Reminds Stockholders of the Class Action Lawsuit Against CTO Realty Growth, Inc.

Robbins LLP is Investigating Allegations that CTO Realty Growth, Inc. (CTO) Misled Investors Regarding its Financial Prospects
11. August 2025 19:21 ET | Quelle: Robbins LLP

Spectrum Pharmaceuticals, Inc. (SPPI) Investors: Contact Robbins LLP for Information About the Class Action Against Spectrum Pharmaceuticals, Inc.

Robbins LLP announces a class action against Spectrum Pharmaceuticals (SPPI) for alleged securities law violations tied to its cancer drug apaziquone.
11. August 2025 19:00 ET | Quelle: Robbins LLP

Investor Alert: Robbins LLP Informs Investors of the SelectQuote, Inc. Class Action Lawsuit

Robbins LLP is Investigating Allegations that SelectQuote, Inc. (SLQT) Violated the False Claims Act

Vorherige Seite

Nächste Seite